Answer
Nov 06, 2025 - 11:48 AM
Robaxin (methocarbamol) is classified as a pregnancy category C drug, meaning that its safety in pregnancy has not been well established. Animal studies have not shown clear harm, but there are no adequate studies in pregnant women. Robaxin should only be used during pregnancy if the potential benefits outweigh the potential risks, and always under the guidance of a healthcare provider.
